Cresco Labs swings to Q2 FY26 net income of USD 15.37 million; revenue rises 15% sequentially to USD 173 million

Reuters2026/08/06 10:41

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cresco Labs posted Q2 revenue of USD 173 million, up 15% sequentially; net income swung to USD 15 million from a loss.
Adjusted EBITDA (non-GAAP) climbed 20% sequentially to USD 40 million, lifting the adjusted margin to 22.8% from 21.7%.
SGA rose to USD 63 million, while adjusted SGA (non-GAAP) increased to USD 55 million; costs reflected MA and uplisting preparedness.
Cash and restricted cash totaled USD 67 million; senior secured term loan stood at USD 311 million, with a USD 19 million mortgage loan.
Management cited improved gross profit dollars at acquired Pennsylvania dispensaries; said federal rescheduling could boost economics by removing 280E.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cresco Labs Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cresco Labs swings to Q2 FY26 net income of USD 15.37 million; revenue rises 15% sequentially to USD 173 million

You may also like

Crypto prices